Q32 Bio to Participate in Upcoming September Investor Conferences
Company executives will present the firm's technology and business story to investors, seeking to increase visibility and attract interest in its defense and industrial AI offerings.
- On Tuesday, technology and healthcare firms including Palladyne AI, Q32 Bio, BridgeBio, Editas Medicine, and Gates Industrial Corporation announced management will participate in investor conferences throughout September 2026.
- Management teams use these interactive sessions to communicate material information and business updates directly to shareholders while providing insights into product pipelines, market strategies, and company performance.
- Editas Medicine and IDEAYA Biosciences will detail progress on precision medicine and genetic therapy pipelines at the Cantor Global Healthcare Conference and Wells Fargo Healthcare Conference, while industrial peers address technological advancements.
- Executives including Ben Wolff, CEO of Palladyne, and Ivo Jurek, CEO of Gates Industrial Corporation, will address market strategies and technological advancements during fireside chats at the Jefferies Global Industrials Conference.
- Interested parties can access live audio webcasts through companies' investor relations websites, with archived replays available for approximately 30 days following each event.
17 Articles
17 Articles
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will…
North Bay Nipissing
Financial PostProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences…
BridgeBio to Participate in September Investor Conferences
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate…
Q32 Bio to Participate in Upcoming September Investor Conferences
WALTHAM, Mass., Sept. 1, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will participate…
ParrySound.com
The Hamilton SpectatorSatellos to Participate in Upcoming Investor Conferences
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in September.
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
